Guest Host: Rebecca Roberts

The genetic material in our cells make us who we are. But since 1982, the U.S. Patent and Trade Office has issued tens of thousands of patents to private companies for gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual property.


  • Joshua D. Sarnoff Professor of the Practice of Law, American University's Washington College of Law
  • Hans Sauer Associate General Counsel for Intellectual Property, Biotechnology Industry Organization
  • Shobita Parthasarathy Co-Director, Science, Technology and Public Policy Program, Ford School of Public Policy, University of Michigan; author, "Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care" (MIT Press)

Topics + Tags


comments powered by Disqus
Most Recent Shows

The Politics Hour — March 16, 2018

Friday, Mar 16 2018Maryland Senator Ben Cardin joins us to talk about the youth movement against gun violence, Russian sanctions, and more. D.C. Councilmember Mary Cheh shares her thoughts on relief for high water bills and news that D.C. Public Schools is taking over an all girls charter school.